Skip to content

Multimodal Observation and Mechanism Study of Brain Function Changes in Parkinson's Disease

Multimodal Observation and Mechanism Study of Brain Function Changes in Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096984
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Control group:None

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Enrollment Criteria for PD Group: 1. A definite diagnosis of PD, 40y<=age<=65y; 2. PD is classified as TD-PD or PIGD-PD; 3. PD stage is H&Y grade <=2.5; 4. Medication: no oral trihexyphenidyl in the past 1 week; 5. Tremor in subjects with TD-PD manifested as limb tremor; Subjects with PIGD-PD present with bradykinesia of the upper limbs; 6. No contraindications to trihexyphenidyl use: cognitive or behavioral abnormalities (MoCA<26), voiding disorders, prostatic hypertrophy, angle-closure glaucoma. Enrollment criteria for normal control group: Gender, age matching, signed informed consent, and agreed to participate in clinical data collection and neuroelectrophysiological measurements.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for PD Group: 1. TMS/electrophysiological contraindications: there is a metal object near the head; Presence of a history of epilepsy or a family history of epilepsy; Severe cardiovascular disease; History of non-reversible brain surgery; 2. Have a clear history of stroke, moderate to severe brain trauma, hydrocephalus, brain surgery or brain tumor in the past; 3. Severe psychiatric symptoms; 4. Unable to cooperate with the completion of the test. Exclusion Criteria for Normal Control Group: 1. History of neurodegenerative disease or related symptoms and signs; 2. Have a clear history of stroke, moderate to severe brain trauma, hydrocephalus, brain surgery or brain tumor in the past; 3. Severe cognitive impairment or psychiatric symptoms; 4. Unable to cooperate with the completion of the test

Design outcomes

Primary

MeasureTime frame
Short latency afferent inhibition;

Secondary

MeasureTime frame
Resting motion threshold;Incoming-outgoing curves;Resting period;Interhemispheric inhibition;Brain activation;

Countries

China

Contacts

Public ContactZhenguo Liu

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

liuzhenguo@xinhuamed.com.cn+86 136 0183 1431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026